共 229 条
[1]
Pellegriti G(2013)Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors J Cancer Epidemiol 2013 965212-2921
[2]
Frasca F(2014)Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Can Res 74 2913-394
[3]
Regalbuto C(2013)New developments in the diagnosis and treatment of thyroid cancer CA Cancer J Clin 63 374-1067
[4]
Squatrito S(2016)Biologic and clinical perspectives on thyroid cancer N Engl J Med 375 1054-93
[5]
Vigneri R(2015)What is the optimal treatment of papillary thyroid cancer? Adv Surg 49 79-388
[6]
Rahib L(2014)The role of surgery in the current management of differentiated thyroid cancer Endocrine 47 380-111
[7]
Smith BD(2018)Lymph node metastases papillary thyroid carcinoma and their importance in recurrence of disease Med Arch 72 108-1433
[8]
Aizenberg R(2013)Breakthrough of the year 2013. Cancer immunotherapy Science 342 1432-715
[9]
Rosenzweig AB(2020)Immunotherapy discontinuation—how, and when? Data from melanoma as a paradigm Nat Rev Clin Oncol 17 707-62.e24
[10]
Fleshman JM(2020)A Phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer Cell 183 347-787